With Covid-19 under control to some extent, preventing transmission is the aim of next-generation vaccines. Many believe those vaccines will be delivered through a nasal inhaler. The mode of delivery could stop transmission by creating immunity where the virus enters the body. India already has a nasal vaccine, though its effectiveness is unknown, and it was designed in the US. Researchers Michael Diamond and David Curiel, both professors at the Washington University School of Medicine, pitched their vaccine to Big Pharma in the US, no one was interested, so they approached Indian vaccine maker Bharat Biotech, which received approval last […]
The story India issues licenses for nasal Covid-19 vaccine as seen on Thaiger News.